MicroRNAs as prognostic markers in prostate cancer.

Suer, Ilknur; Guzel, Esra; Karatas, Omer F; Creighton, Chad J; Ittmann, Michael; Ozen, Mustafa

Suer, Ilknur; Guzel, Esra; Karatas, Omer F; Creighton, Chad J; Ittmann, Michael; Ozen, Mustafa.

Affiliation

Suer I; Department of Medical Genetics, Istanbul University, Division of Medical Genetics, Istanbul Faculty of Medicine, Istanbul, Turkey.
Guzel E; Department of Molecular Biology and Genetics, Institute of Health Sciences, University of Health Sciences, Istanbul, Turkey.
Karatas OF; Molecular Biology and Genetics Department, Erzurum Technical University, Erzurum, Turkey.
Creighton CJ; Department of Medicine and Dan L. Duncan Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, Texas.
Ittmann M; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Ozen M; Michael E. DeBakey VAMC, Houston, Texas.

Prostate ; 79(3): 265-271, 2019 02.

Article de En | MEDLINE | ID: mdl-30345533

Sujet(s)
Mots clés

microRNAs; prognosis; progression; prostate cancer; recurrence

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / MicroARN / Récidive tumorale locale Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male / Middle aged Langue: En Journal: Prostate Année: 2019 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google